Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

CLGN

CollPlant Biotechnologies (CLGN)

CollPlant Biotechnologies Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CLGN
DatumZeitQuelleÜberschriftSymbolFirma
04/04/202413h31IH Market NewsUS Index Futures Rise, Oil Dips SlightlyNASDAQ:CLGNCollPlant Biotechnologies Ltd
15/02/202414h19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
15/02/202414h00PR Newswire (US)CollPlant Issues Letter to ShareholdersNASDAQ:CLGNCollPlant Biotechnologies Ltd
25/01/202421h27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLGNCollPlant Biotechnologies Ltd
02/01/202413h09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
29/11/202313h04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
01/11/202312h08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
10/10/202322h15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
22/09/202313h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLGNCollPlant Biotechnologies Ltd
21/09/202313h15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
12/09/202318h20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLGNCollPlant Biotechnologies Ltd
01/09/202322h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
24/08/202313h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
18/07/202322h15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLGNCollPlant Biotechnologies Ltd
26/06/202313h10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
14/06/202313h34Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CLGNCollPlant Biotechnologies Ltd
24/05/202313h05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
18/04/202322h31Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLGNCollPlant Biotechnologies Ltd
11/04/202314h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/04/202314h59Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/04/202314h26Business WireStratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and OrgansNASDAQ:CLGNCollPlant Biotechnologies Ltd
29/03/202313h50Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CLGNCollPlant Biotechnologies Ltd
30/01/202320h54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLGNCollPlant Biotechnologies Ltd
24/01/202313h00PR Newswire (US)CollPlant Issues Letter to ShareholdersNASDAQ:CLGNCollPlant Biotechnologies Ltd
13/01/202312h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CLGNCollPlant Biotechnologies Ltd
11/01/202314h42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLGNCollPlant Biotechnologies Ltd
06/01/202322h31Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/01/202313h06Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CLGNCollPlant Biotechnologies Ltd
04/01/202313h00PR Newswire (US)CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of ObjectivesNASDAQ:CLGNCollPlant Biotechnologies Ltd
03/01/202313h00PR Newswire (US)CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder FormNASDAQ:CLGNCollPlant Biotechnologies Ltd
 Showing the most relevant articles for your search:NASDAQ:CLGN

Kürzlich von Ihnen besucht

Delayed Upgrade Clock